LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹151 Cr | ₹164 Cr | ₹209 Cr | ₹208 Cr | ₹229 Cr |
What is the latest Total Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹151 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹209 Cr |
| Mar2021 | ₹208 Cr |
| Mar2020 | ₹229 Cr |
How is Total Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹151 Cr | -7.93 | |
| Mar2023 | ₹164 Cr | -21.66 | |
| Mar2022 | ₹209 Cr | 0.63 | |
| Mar2021 | ₹208 Cr | -9.16 | |
| Mar2020 | ₹229 Cr | - | |
Compare Total Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹49.9 Cr | -3.4% | -6.5% | -61% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -3.4% |
-6.5% |
-61% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses